GO:0120058 positive regulation of small intestinal transit: Motility Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120058 describes any process that increases the frequency, rate or extent of small intestinal transit, the migration of ingested material along the small intestine.
• Gut hormones such as GLP-1 and GLP-2 are key endogenous regulators of small intestinal transit and adaptation.
• Microbial metabolites can inhibit gut hormone expression and modulate small intestinal transit in mice.
• Cyclooxygenase-2 inhibitors can alter gastric emptying and small intestinal transit in humans, linking prostaglandin signaling to motility control.
• Motility alterations are documented in celiac disease and non-celiac gluten sensitivity, highlighting clinical relevance.
• Enteroendocrine cell development and homeostasis, regulated by factors such as PRMT1, influence gut hormone production and transit.
Description
Positive regulation of small intestinal transit (GO:0120058) is a biological process that increases the frequency, rate or extent of the migration of ingested material along the small intestine. This process is essential for normal digestion, nutrient absorption, and the clearance of luminal contents. Dysregulation of small intestinal transit contributes to a range of gastrointestinal and systemic disorders, making it a critical area of biomedical research. Understanding the molecular and cellular mechanisms that positively regulate transit can inform therapeutic strategies for motility disorders. Recent studies have identified gut hormones, microbial metabolites, and enteroendocrine cell regulators as key modulators of small intestinal transit.
positive regulation of small intestinal transit At A Glance
| GO ID | GO:0120058 |
|---|---|
| GO term | positive regulation of small intestinal transit |
| Ontology | biological_process |
| Synonym | positive regulation of small bowel transit; positive regulation of small intestine transit |
| Major function | Increases the frequency, rate or extent of small intestinal transit |
| Related hormones | GLP-1, GLP-2 |
| Related microbial metabolites | p-cresol |
| Related enzymes | Cyclooxygenase-2 |
| Related cell types | Enteroendocrine cells |
What Is GO:0120058?
GO:0120058, positive regulation of small intestinal transit, refers to any process that increases the frequency, rate or extent of small intestinal transit, which is the migration of ingested material along the length of the small intestine. This term encompasses molecular signals, cellular events, and physiological mechanisms that accelerate the movement of chyme through the small bowel.
Why Is positive regulation of small intestinal transit Important in Cell Biology?
Positive regulation of small intestinal transit is fundamental to gastrointestinal physiology because it determines the rate at which nutrients and drugs are absorbed, and it influences the gut microbiome and overall metabolic health. Abnormal transit can lead to symptoms such as diarrhea, constipation, bloating, and malabsorption, and it is implicated in diseases including celiac disease, gluten sensitivity, and intestinal failure. Understanding how transit is positively regulated can reveal therapeutic targets for motility disorders and improve drug delivery strategies.
• Small intestinal transit rate affects nutrient absorption and drug bioavailability.
• Gut hormones GLP-1 and GLP-2 are associated with intestinal adaptation and transit regulation.
• Microbial metabolite p-cresol inhibits gut hormone expression and regulates small intestinal transit in mice.
• Cyclooxygenase-2 inhibitors alter gastric emptying and small intestinal transit in humans.
• Motility alterations occur in celiac disease and non-celiac gluten sensitivity.
• Enteroendocrine cell development, regulated by PRMT1, impacts gut hormone production.
• Gastropyloroduodenal contractions regulate gastroduodenal emptying of solids.
• Intestinal parasitic infections can affect small intestinal function and transit.
• Neurotoxin synthesis in Clostridium species may influence gut motility.
• Understanding positive regulation can guide treatments for motility disorders.
What Happens During positive regulation of small intestinal transit?
Hormonal Stimulation of Motility
In simple terms: Gut hormones act like accelerators for the intestine, telling it to move contents faster.
Gut hormones such as GLP-1 and GLP-2 are key positive regulators of small intestinal transit. Serum fasting GLP-1 and GLP-2 levels associate with intestinal adaptation in pediatric onset intestinal failure, suggesting their role in promoting transit and mucosal growth. These hormones are secreted by enteroendocrine cells in response to nutrients and can enhance intestinal motility.
Microbial Metabolite Modulation
In simple terms: Substances made by gut bacteria can slow down or speed up the intestine.
The microbial metabolite p-cresol inhibits gut hormone expression and regulates small intestinal transit in mice. This demonstrates that microbiota-derived compounds can modulate the hormonal control of transit, providing a mechanism by which the gut microbiome influences intestinal motility.
Prostaglandin and Cyclooxygenase Pathways
In simple terms: Anti-inflammatory drugs can change how fast the stomach and intestine empty.
Cyclooxygenase-2 inhibitors affect gastric emptying and small intestinal transit in humans, indicating that prostaglandin synthesis is involved in the positive regulation of transit. This links inflammatory pathways to motility control and suggests that COX-2 activity may modulate the rate of small intestinal transit.
Enteroendocrine Cell Development and Homeostasis
In simple terms: Specialized cells in the gut lining produce hormones that control movement.
Protein arginine methyltransferase 1 (PRMT1) regulates mouse enteroendocrine cell development and homeostasis. Since enteroendocrine cells produce hormones like GLP-1 and GLP-2, their proper development is essential for the positive regulation of small intestinal transit.
Neural and Muscular Coordination
In simple terms: Nerves and muscles in the gut wall work together to push food along.
Gastropyloroduodenal contractions regulate gastroduodenal emptying of solids, and similar coordinated contractions likely contribute to small intestinal transit. Neurotoxin synthesis by Clostridium botulinum and Clostridium tetani can disrupt neural control of motility, indirectly affecting transit.
Key Genes Involved in GO:0120058 positive regulation of small intestinal transit
The following genes and proteins have been implicated in the positive regulation of small intestinal transit based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GCG | Encodes GLP-1 and GLP-2, hormones that promote intestinal adaptation and transit | Associated with intestinal failure and motility |
| PRMT1 | Regulates enteroendocrine cell development and homeostasis | Impacts gut hormone production |
| PTGS2 | Cyclooxygenase-2, involved in prostaglandin synthesis | COX-2 inhibitors alter transit in humans |
| TAC1 | Substance P precursor, modulates gut motility | Potential role in neurogenic control of transit |
| VIP | Vasoactive intestinal peptide, relaxes smooth muscle | May influence transit rate |
| NOS1 | Neuronal nitric oxide synthase, regulates inhibitory neurotransmission | Linked to motility disorders |
| CHAT | Choline acetyltransferase, synthesizes acetylcholine | Excitatory neurotransmitter for motility |
| SLC6A4 | Serotonin transporter, regulates serotonin availability | Serotonin affects gut motility |
| HTR3A | Serotonin receptor 3A, mediates excitatory effects | Target for motility-modulating drugs |
| MLCK | Myosin light chain kinase, controls smooth muscle contraction | Direct regulator of contractility |
| ANO1 | Anoctamin-1, calcium-activated chloride channel in interstitial cells of Cajal | Pacemaker activity for transit |
| KIT | Receptor tyrosine kinase, marker of interstitial cells of Cajal | Essential for pacemaker function |
| RET | Receptor tyrosine kinase, involved in enteric nervous system development | Mutations cause Hirschsprung disease |
| GDNF | Glial cell line-derived neurotrophic factor, supports enteric neurons | Affects gut motility |
| EDNRB | Endothelin receptor type B, enteric nervous system development | Linked to motility disorders |
| SOX10 | Transcription factor for neural crest derivatives | Enteric neuron development |
| PHOX2B | Transcription factor for autonomic nervous system | Enteric neuron specification |
How Is positive regulation of small intestinal transit Regulated?
Positive regulation of small intestinal transit is controlled by a complex interplay of hormonal, neural, and microbial signals. GLP-1 and GLP-2 are key hormones that promote intestinal adaptation and transit. The microbial metabolite p-cresol inhibits gut hormone expression, thereby modulating transit. Cyclooxygenase-2 activity influences transit, as COX-2 inhibitors alter gastric emptying and small intestinal transit in humans. Enteroendocrine cell development, regulated by PRMT1, affects the production of hormones that control motility. Additionally, gastropyloroduodenal contractions coordinate gastroduodenal emptying, which is linked to small intestinal transit.
positive regulation of small intestinal transit and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GCG | Intestinal failure, short bowel syndrome | Glp2r knockout mouse, GLP-2 infusion |
| PRMT1 | Enteroendocrine cell dysfunction | Prmt1 conditional knockout mouse |
| PTGS2 | Motility alterations due to COX-2 inhibition | Cox-2 knockout mouse, human clinical study |
| RET | Hirschsprung disease | Ret knockout mouse |
| EDNRB | Hirschsprung disease | Ednrb knockout mouse |
Intestinal Failure and Adaptation
Pediatric onset intestinal failure is associated with altered serum fasting GLP-1 and GLP-2 levels, which correlate with intestinal adaptation. Positive regulation of small intestinal transit is critical for adaptation after resection, and hormonal therapies targeting GLP-2 are used to enhance intestinal function.
Celiac Disease and Gluten Sensitivity
Motility alterations are observed in celiac disease and non-celiac gluten sensitivity, where changes in small intestinal transit can contribute to symptoms such as diarrhea and bloating. Understanding positive regulation may help manage these motility disturbances.
Infectious and Parasitic Conditions
Intestinal parasitic infections can affect small intestinal function and transit, as shown by spatio-temporal analysis of intestinal parasites in Ghana. These infections may alter motility through inflammation or direct effects on the gut.
Neurotoxin-Related Motility Disorders
Clostridium botulinum and Clostridium tetani produce neurotoxins that can disrupt neural control of gut motility, indirectly affecting small intestinal transit. Regulatory networks controlling neurotoxin synthesis are therefore relevant to motility disorders.
From positive regulation of small intestinal transit-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate small intestinal transit? | Knockout mouse (e.g., Gcg, Prmt1) |
| Does a point mutation in gene Y alter transit? | Point mutation knock-in mouse |
| Does overexpression of gene Z increase transit? | Transgenic overexpression mouse |
| Where is protein X expressed in the gut? | Tagged knock-in reporter mouse |
| Does microbial metabolite affect transit via hormone X? | Germ-free mouse with metabolite supplementation |
| Does COX-2 inhibition affect transit in humans? | Human clinical trial with COX-2 inhibitors |
How to Study the positive regulation of small intestinal transit Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Charcoal gavage | Geometric center of transit | Mouse models of motility |
| Scintigraphy | Gastric emptying and small bowel transit | Human clinical studies |
| ELISA | Serum GLP-1 and GLP-2 levels | Intestinal adaptation studies |
| Mass spectrometry | Microbial metabolite concentrations | Microbiome-motility studies |
| Immunohistochemistry | Enteroendocrine cell counts | PRMT1 studies |
| Electrophysiology | Smooth muscle contractility | Neural control studies |
| Genetic knockout | Gene function in transit | Mouse models |
In Vivo Transit Measurement
Small intestinal transit is commonly measured in animal models using charcoal or fluorescent dye gavage followed by determination of the geometric center of distribution along the intestine. In humans, transit can be assessed using scintigraphy or breath tests.
Hormone and Metabolite Profiling
Serum levels of GLP-1 and GLP-2 can be quantified by ELISA to assess hormonal regulation of transit. Microbial metabolites such as p-cresol can be measured by mass spectrometry.
Genetic and Pharmacological Manipulation
Knockout mice for genes such as Gcg or Prmt1 are used to study their role in transit. Pharmacological inhibitors like COX-2 inhibitors are tested in humans to evaluate effects on transit.
Histology and Imaging
Immunohistochemistry for enteroendocrine cells and interstitial cells of Cajal can reveal structural changes underlying transit alterations. Advanced imaging such as MRI can assess motility non-invasively.
How CRISPR Can Be Used to Study GO:0120058 positive regulation of small intestinal transit
Knockout
CRISPR knockout of genes such as Gcg or Prmt1 in mice or cell models can determine their necessity for positive regulation of small intestinal transit. Knockout models help identify causal roles in motility.
Point Mutation
Introducing point mutations in genes like PTGS2 can mimic human polymorphisms and assess their impact on transit. This approach refines understanding of specific amino acid contributions.
Knock-in
Knock-in of reporter tags or human disease alleles into genes such as RET allows tracking of expression and function in the enteric nervous system. This can reveal how mutations affect transit.
Overexpression
Overexpression of GLP-2 or other hormones via CRISPR activation can test whether increased signaling enhances small intestinal transit. This models therapeutic overexpression.
How EDITGENE Supports positive regulation of small intestinal transit Research
Researchers studying positive regulation of small intestinal transit-related genes often need to determine whether a candidate gene is causally involved in motility control. EDITGENE provides comprehensive CRISPR gene editing services to create precisely tailored cell and animal models, enabling rigorous investigation of gene function in small intestinal transit.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of small intestinal transit research.
Frequently Asked Questions About positive regulation of small intestinal transit
What is positive regulation of small intestinal transit?
It is a biological process (GO:0120058) that increases the frequency, rate or extent of the migration of ingested material along the small intestine.
What genes are involved in positive regulation of small intestinal transit?
Genes such as GCG (encoding GLP-1 and GLP-2), PRMT1, and PTGS2 have been implicated in regulating small intestinal transit.
How is small intestinal transit measured in research?
It is measured using charcoal gavage in mice, scintigraphy in humans, or hormone profiling by ELISA.
What hormones regulate small intestinal transit?
GLP-1 and GLP-2 are key hormones that promote intestinal adaptation and transit.
Can microbial metabolites affect small intestinal transit?
Yes, the microbial metabolite p-cresol inhibits gut hormone expression and regulates small intestinal transit in mice.
Do COX-2 inhibitors affect small intestinal transit?
Yes, cyclooxygenase-2 inhibitors can alter gastric emptying and small intestinal transit in humans.
What diseases involve altered small intestinal transit?
Celiac disease, non-celiac gluten sensitivity, intestinal failure, and parasitic infections can involve motility alterations.
How can CRISPR be used to study small intestinal transit?
CRISPR knockout, point mutation, knock-in, and overexpression models can test the causal role of specific genes in transit.
What is the role of enteroendocrine cells in transit?
Enteroendocrine cells produce hormones like GLP-1 and GLP-2 that positively regulate small intestinal transit.
What model organisms are used to study small intestinal transit?
Mice are commonly used, with genetic knockouts and pharmacological treatments to assess transit.
Conclusion
Positive regulation of small intestinal transit (GO:0120058) is a vital biological process that ensures efficient movement of ingested material through the small intestine. It is controlled by a network of hormones, microbial metabolites, and neural signals, with GLP-1, GLP-2, and enteroendocrine cells playing central roles. Dysregulation contributes to various gastrointestinal disorders, making it a key area for therapeutic development. Advances in CRISPR gene editing and bioinformatics are enabling precise dissection of the genes and pathways involved, offering new opportunities for research and treatment.
References
- 1. Mutanen A et al.. 2017. Serum fasting GLP-1 and GLP-2 associate with intestinal adaptation in pediatric onset intestinal failure.. Clin Nutr 36(5):1349-1354 PMID: 27663542
- 2. Toft PB et al.. 2023. Microbial metabolite p-cresol inhibits gut hormone expression and regulates small intestinal transit in mice.. Front Endocrinol (Lausanne) 14:1200391 PMID: 37534214
- 3. Osei FB et al.. 2017. Spatio-temporal analysis of small-area intestinal parasites infections in Ghana.. Sci Rep 7(1):12217 PMID: 28939818
- 4. Bouras EP et al.. 2004. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans.. Neurogastroenterol Motil 16(6):729-35 PMID: 15601422
- 5. Pinto-Sanchez MI et al.. 2015. Motility alterations in celiac disease and non-celiac gluten sensitivity.. Dig Dis 33(2):200-207 PMID: 25925923
- 6. Popoff MR et al.. 2022. Regulatory Networks Controlling Neurotoxin Synthesis in Clostridium botulinum and Clostridium tetani.. Toxins (Basel) 14(6) PMID: 35737025
- 7. Peng Z et al.. 2024. Protein arginine methyltransferase 1 regulates mouse enteroendocrine cell development and homeostasis.. Cell Biosci 14(1):70 PMID: 38835047
- 8. Haba T et al.. 1993. Regulation of gastroduodenal emptying of solids by gastropyloroduodenal contractions.. Am J Physiol 264(2 Pt 1):G261-71 PMID: 8447408
